Estimated Economic Costs of Obesity to U.S. Business

Objective. To estimate the economic costs of obesity to U. S. business. Methods. Standard epidemiologic methods for risk attribution and techniques for ascertaining cost of illness were used to estimate obesity-attributable expenditures on selected employee benefits, including health, life, and disability insurance and paid sick leave by private-sector firms in the U. S. in 1994. Data were obtained from a variety of secondary sources, including the National Health Interview Survey, reports from the Bureau of Labor Statistics and other federal agencies, and the published literature. Attention was focused on employees between the ages of 25 and 64 years who were classified according to body mass index (BMI) as “nonobese” (BMI < 25 kg/m 2), “mildly obese” (BMI = 25–28. 9 kg/m 2), or “moderately to severely obese” (BMI ≥ 29 kg/m 2). Results. The cost of obesity to U. S. business in 1994 was estimated to total 12. 7 billion, including 2. 6 billion as a result of mild obesity and 10. 1 billion due to moderate to severe obesity. Health insurance expenditures constituted 7. 7 billion of the total amount, representing 43% of all spending by U. S. business on coronary heart disease, hypertension, type 2 diabetes, hypercholesterolemia, stroke, gallbladder disease, osteoarthritis of the knee, and endometrial cancer. Obesity-attributable business expenditures on paid sick leave, life insurance, and disability insurance amounted to 2. 4 billion, 1. 8 billion, and 800 million, respectively. Conclusions. The health-related economic cost of obesity to U. S. business is substantial, representing approximately 5% of total medical care costs. Further research is needed to determine the cost-effectiveness of worksite weight management programs and of other efforts to reduce the prevalence of obesity in the U. S. workforce.